<DOC>
	<DOCNO>NCT02569541</DOCNO>
	<brief_summary>To evaluate safety effectiveness oral sodium fusidate ( CEM-102 ) chronic antibiotic treatment bone joint infection .</brief_summary>
	<brief_title>Oral Sodium Fusidate ( CEM-102 ) Treatment Staphylococcal Bone Joint Infections Subjects Whom Chronic Antibiotic Suppressive Therapy Indicated</brief_title>
	<detailed_description>Prospective , open-label , non-randomized , single-arm trial evaluate safety effectiveness CEM-102 chronic antibiotic suppressive therapy bone joint infection . Subjects enrol study must refractory staphylococcal bone joint infection require suppressive antibiotic therapy ( e.g . infection manage complete removal infect bone foreign material , refractory infection respond previous treatment , candidate long-term intravenous antibiotic therapy ) .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Arthritis , Infectious</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Fusidic Acid</mesh_term>
	<criteria>Adolescents 12 18 year must weigh &gt; 60 kg Bone joint infection due inclusionary pathogen demonstrate culture sample obtain within 6 week prior enrollment Not candidate , determine Investigator , suitable alternative therapy After completion 12 week companion antibiotic , must suitable candidate CEM102 monotherapy chronic treatment Requires concomitant treatment OATP1B1 OATP1B3 substrate , particular , statin ( HMGCoA reductase inhibitor ) Known severe renal impairment , indicate estimate CrCl &lt; 30 mL/min ( CockcroftGault calculation ) Evidence significant liver disease : ALT &gt; 3 Ã— ULN direct bilirubin &gt; ULN ; know cirrhosis decompensation ( i.e . ChildPugh Class B C disease )</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>fusidic acid</keyword>
	<keyword>prosthetic joint infection</keyword>
	<keyword>bone infection</keyword>
	<keyword>osteomyelitis</keyword>
</DOC>